Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
WIRB-Copernicus Aquires Alliance Biosciences
WIRB-Copernicus Group (WCG), a global provider of regulatory and ethical review services for clinical research, acquired Alliance Biosciences in July of 2014. With this addition, WCG Biosafety will be able to manage the entire continuum of biocontainment oversight, helping to ensure that research involving potentially hazardous agents and vectors complies with the appropriate regulatory requirements from laboratory design and drug discovery through clinical testing and therapeutic application.
Pirbright Institute Builds Avian Diseases Lab
The Pirbright Institute broke ground in July of 2014 on the $26 million Avian Diseases Lab in the United Kingdom. The 38,000-sf facility will provide CL-2 biocontainment space for in vitro research on infectious diseases affecting poultry and other livestock. Housing up to 90 scientists, the project will support the relocation of the Avian Viral Diseases program from Compton to Pirbright.
Murray State University Builds Veterinary and Science Facilities
Murray State University will begin building the $36.6 million Breathitt Veterinary Center in September of 2014 in Hopkinsville, Ky. Designed by Foil Wyatt Architects & Planners, the 61,000-sf facility will open in 2016. Additionally, work will begin in February of 2015 on the $36.8 million Engineering and Physics building; completion is slated for August of 2016.
United Therapeutics Plans Research Triangle Park Facility
United Therapeutics is planning to build a biomedical R&D facility in Research Triangle Park, N.C. Comprising 250,000 sf of new construction and 150,000 sf of renovated space, the project will provide vivarium space for pigs and xenotransplantation research laboratories. The facility will enable the creation of genetically modified pig embryos which grow to be born with human lungs that can be harvested for transplants and tissue grafts.
The Jackson Laboratory Creates Wuhan Cancer Research Facility
The Jackson Laboratory (JAX) is partnering with Wuhan Frasergen Bioinformatics to create a biomedical research center in Wuhan, China. The facility will support the transfer of basic research to clinical care to provide personalized medicine solutions for cancer and hereditary diseases. JAX's immunocompromised mice will be used as hosts for tumors donated by Chinese patients to enable the development of pharmaceutical therapies.